GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC–MS readout

David Falck, Manfred Wuhrer

Published: 2024-02-21 DOI: 10.1038/s41596-024-00963-7

IgG Fc glycosylation

GlYcoLISA

LC-MS

antigen-specific

immunosorbent assay

AI 解读

Extended

Extended Data Table 1 Compositions, nomenclature and structure

Full size table

Supplementary information

Reporting Summary

In vitro reconstitution of COPII vesicles fromArabidopsis thalianasuspension-cultured cells

Anaerobic cryoEM protocols for air-sensitive nitrogenase proteins

Monomicellar assembly to synthesize structured and functional mesoporous carbonaceous nanomaterials

An optimized culture system for efficient derivation of porcine expanded potential stem cells from preimplantation embryos and by reprogramming somatic cells

Measuring DNA modifications with the comet assay: a compendium of protocols

Design and build of small-scale magnetic soft-bodied robots with multimodal locomotion

A practical guide to scanning light-field microscopy with digital adaptive optics

Reproducible mass spectrometry data processing and compound annotation in MZmine 3

Genetic in vivo engineering of human T lymphocytes in mouse models

Digital postprocessing and image segmentation for objective analysis of colorimetric reactions

查看全部

Sections

Figures

References

Extended
Supplementary information

Lai, K. N. et al. IgA nephropathy. Nat. Rev. Dis. Prim. 2, 16001 (2016).
Wuhrer, M. et al. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 7, 4070–4081 (2007).
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M. & Dwek, R. A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25, 21–50 (2007).
de Haan, N., Falck, D. & Wuhrer, M. Monitoring of immunoglobulin N- and O-glycosylation in health and disease. Glycobiology 30, 226–240 (2020).
Ferrara, C. et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose. Proc. Natl Acad. Sci. USA 108, 12669–12674 (2011).
van Osch, T. L. J. et al. Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation. J. Immunol. 207, 1545–1554 (2021).
Kapur, R., Einarsdottir, H. K. & Vidarsson, G. IgG-effector functions: ‘the good, the bad and the ugly’. Immunol. Lett. 160, 139–144 (2014).
Shields, R. L. et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277, 26733–26740 (2002).
Shibata-Koyama, M. et al. Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils. Exp. Hematol. 37, 309–321 (2009).
Beck, A. & Reichert, J. M. Marketing approval of mogamulizumab: a triumph for glyco-engineering. MAbs 4, 419–425 (2012).
Dekkers, G. et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front. Immunol. 8, 877 (2017).
Vergroesen, R. D. et al. B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation. Ann. Rheum. Dis. 77, 956–958 (2018).
Trbojevic-Akmacic, I., Abdel-Mohsen, M., Falck, D. & Rapp, E. Editorial: immunoglobulin glycosylation analysis: state-of-the-art methods and applications in immunology. Front. Immunol. 13, 923393 (2022).
Bondt, A. et al. ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis. Ann. Rheum. Dis. 77, 1130–1136 (2018).
Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371, eabc8378 (2021).
Kapur, R. et al. A prominent lack of IgG1–Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123, 471–480 (2014).
Bartsch, Y. C. et al. IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants. J. Allergy Clin. Immunol. 146, 652–666 e611 (2020).
Wojcik, I. et al. A functional spleen contributes to afucosylated IgG in humans. Sci. Rep. 11, 24045 (2021).
Cao, Y. et al. Cytokines in the immune microenvironment change the glycosylation of IgG by regulating intracellular glycosyltransferases. Front. Immunol. 12, 724379 (2021).
Larsen, M. D. et al. Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination. Nat. Commun. 12, 5838 (2021).
Buhre, J. S. et al. mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine. Front. Immunol. 13, 1020844 (2023).
Pongracz, T. et al. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19. EBioMedicine 78, 103957 (2022).
Kemna, M. J. et al. Galactosylation and sialylation levels of IgG predict relapse in patients with PR3–ANCA-associated vasculitis. EBioMedicine 17, 108–118 (2017).
Wang, J. et al. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol. Cell. Proteom. 10, 004655 (2011).
Ercan, A. et al. Estrogens regulate glycosylation of IgG in women and men. JCI Insight 2, e89703 (2017).
Washburn, N. et al. Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity. Proc. Natl Acad. Sci. USA 112, E1297–E1306 (2015).
Falck, D., Jansen, B. C., de Haan, N. & Wuhrer, M. High-throughput analysis of IgG Fc glycopeptides by LC–MS. Methods Mol. Biol. 1503, 31–47 (2017).
Selman, M. H. et al. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC–MS using a sheath-flow ESI sprayer interface. J. Proteom. 75, 1318–1329 (2012).
Kammeijer, G. S. et al. Dopant enriched nitrogen gas combined with sheathless capillary electrophoresis-electrospray ionization-mass spectrometry for improved sensitivity and repeatability in glycopeptide analysis. Anal. Chem. 88, 5849–5856 (2016).
Falck, D. et al. Glycoforms of immunoglobulin G based biopharmaceuticals are differentially cleaved by trypsin due to the glycoform influence on higher-order structure. J. Proteome Res. 14, 4019–4028 (2015).
Simurina, M. et al. Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases. Gastroenterology 154, e1310 (2018).
Jansen, B. C. et al. LaCyTools: a targeted liquid chromatography–mass spectrometry data processing package for relative quantitation of glycopeptides. J. Proteome Res. 15, 2198–2210 (2016).
Falck, D. et al. Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody. MAbs 13, 1865596 (2021).
Scherer, H. U. et al. Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum. Proteom. Clin. Appl. 3, 106–115 (2009).
Rombouts, Y. et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann. Rheum. Dis. 74, 234–241 (2015).
Wuhrer, M. et al. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation. J. Proteome Res. 14, 1657–1665 (2015).
Sonneveld, M. E. et al. Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation. Sci. Rep. 7, 8187 (2017).
Kapur, R. et al. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br. J. Haematol. 166, 936–945 (2014).
Sonneveld, M. E. et al. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. Br. J. Haematol. 176, 651–660 (2017).
Sonneveld, M. E. et al. Fc-glycosylation in human IgG1 and IgG3 is similar for both total and anti-red-blood cell anti-K antibodies. Front. Immunol. 9, 129 (2018).
Siekman, S. L. et al. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity. Front. Immunol. 13, 993354 (2022).
Ackerman, M. E. et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Invest. 123, 2183–2192 (2013).
Lu, L. L. et al. Antibody Fc glycosylation discriminates between latent and active tuberculosis. J. Infect. Dis. 222, 2093–2102 (2020).
Van Coillie, J. et al. The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees. EBioMedicine 87, 104408 (2023).
van Osch, T. L. J. et al. Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions. J. Thromb. Haemost. 20, 3011–3025 (2022).
Bharadwaj, P. et al. Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation. Cell Rep. Med. 3, 100818 (2022).
Sokolova, M. V. et al. Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk. RMD Open. 9, e002705 (2023).
Steffen, U. et al. IgA subclasses have different effector functions associated with distinct glycosylation profiles. Nat. Commun. 11, 120 (2020).
Momcilovic, A. et al. Simultaneous immunoglobulin A and G glycopeptide profiling for high-throughput applications. Anal. Chem. 92, 4518–4526 (2020).
Chandler, K. B. et al. Multi-isotype glycoproteomic characterization of serum antibody heavy chains reveals isotype- and subclass-specific N-glycosylation profiles. Mol. Cell. Proteom. 18, 686–703 (2019).
Overall, M. L., Marzuki, S. & Hertzog, P. J. Comparison of different ELISAs for the detection of monoclonal antibodies to human interferon-α. Implications for antibody screening. J. Immunol. Methods 119, 27–33 (1989).
Yuan, S. et al. Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto’s thyroiditis patients. J. Clin. Endocrinol. Metab. 100, 717–724 (2015).
Sahoo, A. et al. A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques. Sci. Immunol. 7, eabl4102 (2022).
Aoyama, M. et al. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies. MAbs 11, 826–836 (2019).
Scherer, H. U. et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum. 62, 1620–1629 (2010).
Amez Martin, M., Wuhrer, M. & Falck, D. Serum and plasma immunoglobulin G Fc N-glycosylation is stable during Storage. J. Proteome Res. 20, 2935–2941 (2021).
Amez-Martin, M., Wuhrer, M. & Falck, D. Immunoglobulin G glycoprofiles are unaffected by common bottom-up sample processing. J. Proteome Res. 19, 4158–4162 (2020).
de Haan, N. et al. Developments and perspectives in high-throughput protein glycomics: enabling the analysis of thousands of samples. Glycobiology 32, 651–663 (2022).
Thermo Fisher Scientific Inc. Chromatography Troubleshooting Guides—Liquid Chromatography https://www.thermofisher.com/nl/en/home/industrial/chromatography/chromatography-learning-center/chromatography-consumables-resources/chromatography-troubleshooting-guides/chromatography-troubleshooting-guides-liquid-chromatography.html (2006).
Pongracz, T., Vidarsson, G. & Wuhrer, M. Antibody glycosylation in COVID-19. Glycoconj. J. 39, 335–344 (2022).
Vattepu, R., Sneed, S. L. & Anthony, R. M. Sialylation as an important regulator of antibody function. Front. Immunol. 13, 818736 (2022).
Bartsch, Y. C. et al. Sialylated autoantigen-reactive IgG antibodies attenuate disease development in autoimmune mouse models of lupus nephritis and rheumatoid arthritis. Front. Immunol. 9, 1183 (2018).
Sustic, T. et al. Immunoassay for quantification of antigen-specific IgG fucosylation. EBioMedicine 81, 104109 (2022).

GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC–MS readout

Extended

Supplementary information

推荐阅读